2019 HPTN Annual Meeting Presentations

General Plenary

The STI Crisis and Implications for HIV Prevention Research and Implementation – Jeanne Marrazzo

MPTs: Opportunities and Challenges – Sharon Hillier

HIV Risk Compensation in Biomedical HIV Prevention Strategies Among Black Men Who Have Sex With Men in HPTN 073 – Darren Whitfield

HIV Risk Perception and Management Among Men Who Have Sex With Men and Transgender Women in Sub-Saharan Africa: Findings from HPTN 075 – Yamikani Rose Mbilizi

Prevalence and Risk of Sexually Transmitted Infections Among HIV-Infected Index Cases and Their HIV-Uninfected Partners: HPTN 052 – Maganizo Chagomerana

Ending the Pandemic: NIH Directions in HIV Prevention Research – Maureen Goodenow

User Characteristics and Preferences in Using Agents for HIV Prevention – Arianne van der Straten  

Findings and Lessons Learned from HPTN 071 (PopART) – Sarah Fidler/Richard Hayes

Community Engagement in the HPTN 071 (PopART) Study – Musonda Simwinga

General Plenary

NIAID Priorities in HIV/AIDS Research – Anthony Fauci

HPTN: Where We Are and The Way Forward – Myron Cohen

Bending the Curve: Eliminating New HIV Infections in the U.S. – Eugene McCray

HIV/AIDS and Drug Abuse: The Promise of Integrated Care? – Redonna Chandler

Sexualized Drug Use: Global Trends and The Effect on The HIV Epidemic – Steve Shoptaw

General Plenary

Use of Mobile Technology in Clinical Trials – Patrick Sullivan

Ethical Considerations in Design of HIV Prevention Trials Panel Discussion – Deborah Donnell

Statistical Plenary

Estimating HIV Incidence Among Young Women in HPTN 082 Using Baseline HIV Risk Scores – James Moore

The Statistical Analysis of HPTN 071 (PopART) – Deborah Donnell

Trial Designs for Evaluating Integrated HIV Prevention Approaches – Ying Chen

NIAID

Sterile Production Preparation: Equipment, Technique, Monitoring, and Training – Cindy Parker and Irene Rwakazina